Literature DB >> 24395347

TET family proteins: new players in gliomas.

Er-Bao Bian1, Gang Zong, Yong-Sheng Xie, Xiao-Ming Meng, Cheng Huang, Jun Li, Bing Zhao.   

Abstract

DNA methylation at the 5-position of cytosine (5mC) in the mammalian genome has emerged as a pivotal epigenetic event that plays important roles in development, aging and disease. The three members of the TET protein family, which convert 5mC to 5-hydroxymethylcytosine, has provided a potential mechanism resulting in DNA demethylation and maintaining cellular identity. Recent studies have shown that epigenetic modifications play a key role in the regulation of the molecular pathogenesis of gliomas. In this review we focus on demonstrating the TET proteins in DNA demethylation and transcriptional regulation of different target genes. In addition, we address the role of TET proteins in gliomas. This review will provide valuable insights into the potential targets of gliomas, and may open the possibility of novel therapeutic approaches to this fatal disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24395347     DOI: 10.1007/s11060-013-1328-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  70 in total

1.  TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity.

Authors:  Kristine Williams; Jesper Christensen; Marianne Terndrup Pedersen; Jens V Johansen; Paul A C Cloos; Juri Rappsilber; Kristian Helin
Journal:  Nature       Date:  2011-04-13       Impact factor: 49.962

Review 2.  DNA methylation and gene silencing in cancer.

Authors:  Stephen B Baylin
Journal:  Nat Clin Pract Oncol       Date:  2005-12

3.  Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia.

Authors:  N Konstandin; S Bultmann; A Szwagierczak; A Dufour; B Ksienzyk; F Schneider; T Herold; M Mulaw; P M Kakadia; S Schneider; K Spiekermann; H Leonhardt; S K Bohlander
Journal:  Leukemia       Date:  2011-05-31       Impact factor: 11.528

Review 4.  Genetics of adult glioma.

Authors:  McKinsey L Goodenberger; Robert B Jenkins
Journal:  Cancer Genet       Date:  2012-12-11

5.  Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation.

Authors:  Jikui Song; Olga Rechkoblit; Timothy H Bestor; Dinshaw J Patel
Journal:  Science       Date:  2010-12-16       Impact factor: 47.728

6.  [The 2007 World Health Organisation classification of tumours of the central nervous system, comparison with 2000 classification].

Authors:  B Rychlý; H Sidlová; D Daniś
Journal:  Cesk Patol       Date:  2008-04

7.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

8.  Ten-eleven translocation 1 (Tet1) is regulated by O-linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells.

Authors:  Feng-Tao Shi; Hyeung Kim; Weisi Lu; Quanyuan He; Dan Liu; Margaret A Goodell; Ma Wan; Zhou Songyang
Journal:  J Biol Chem       Date:  2013-05-31       Impact factor: 5.157

9.  Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma.

Authors:  Brent A Orr; Michael C Haffner; William G Nelson; Srinivasan Yegnasubramanian; Charles G Eberhart
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

10.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

Authors:  Wei Xu; Hui Yang; Ying Liu; Ying Yang; Ping Wang; Se-Hee Kim; Shinsuke Ito; Chen Yang; Pu Wang; Meng-Tao Xiao; Li-xia Liu; Wen-qing Jiang; Jing Liu; Jin-ye Zhang; Bin Wang; Stephen Frye; Yi Zhang; Yan-hui Xu; Qun-ying Lei; Kun-Liang Guan; Shi-min Zhao; Yue Xiong
Journal:  Cancer Cell       Date:  2011-01-18       Impact factor: 38.585

View more
  10 in total

1.  TET1 Overexpression Mitigates Neuropathic Pain Through Rescuing the Expression of μ-Opioid Receptor and Kv1.2 in the Primary Sensory Neurons.

Authors:  Qiang Wu; Guihua Wei; Fengtao Ji; Shushan Jia; Shaogen Wu; Xinying Guo; Long He; Zhiqiang Pan; Xuerong Miao; Qingxiang Mao; Yong Yang; Minghui Cao; Yuan-Xiang Tao
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

2.  TET3 mediates the activation of human hepatic stellate cells via modulating the expression of long non-coding RNA HIF1A-AS1.

Authors:  Qing-Qing Zhang; Ming-Yi Xu; Yin Qu; Jun-Jie Hu; Zheng-Hong Li; Qi-Di Zhang; Lun-Gen Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 3.  Nerve trauma-caused downregulation of opioid receptors in primary afferent neurons: Molecular mechanisms and potential managements.

Authors:  Bi-Xin Zheng; Ayma Malik; Ming Xiong; Alex Bekker; Yuan-Xiang Tao
Journal:  Exp Neurol       Date:  2020-12-16       Impact factor: 5.330

4.  Drosophila Tet Is Required for Maintaining Glial Homeostasis in Developing and Adult Fly Brains.

Authors:  Felice Frey; Jawdat Sandakly; Mirna Ghannam; Caren Doueiry; Fredrik Hugosson; Johannes Berlandi; Joy N Ismail; Tenzin Gayden; Martin Hasselblatt; Nada Jabado; Margret Shirinian
Journal:  eNeuro       Date:  2022-04-26

5.  Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated TET1 expression.

Authors:  Ashley Ramsawhook; Lara Lewis; Beth Coyle; Alexey Ruzov
Journal:  Clin Epigenetics       Date:  2017-02-13       Impact factor: 6.551

6.  DNA methyltransferase DNMT3a contributes to neuropathic pain by repressing Kcna2 in primary afferent neurons.

Authors:  Jian-Yuan Zhao; Lingli Liang; Xiyao Gu; Zhisong Li; Shaogen Wu; Linlin Sun; Fidelis E Atianjoh; Jian Feng; Kai Mo; Shushan Jia; Brianna Marie Lutz; Alex Bekker; Eric J Nestler; Yuan-Xiang Tao
Journal:  Nat Commun       Date:  2017-03-08       Impact factor: 14.919

Review 7.  Epigenetic modifications in neuropathic pain.

Authors:  Danzhi Luo; Xiaohong Li; Simin Tang; Fuhu Song; Wenjun Li; Guiling Xie; Jinshu Liang; Jun Zhou
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

Review 8.  Recent Molecular Advances in Our Understanding of Glioma.

Authors:  Rohan Ramakrishna; David Pisapia
Journal:  Cureus       Date:  2015-07-23

Review 9.  Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.

Authors:  Reem Saleh; Salman M Toor; Varun Sasidharan Nair; Eyad Elkord
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

Review 10.  Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses.

Authors:  Vibe Skov
Journal:  Cancers (Basel)       Date:  2020-08-06       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.